Getinge (GETI B) Stock Overview
Provides products and solutions for operating rooms, intensive-care units, and sterilization departments in Sweden and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
GETI B Community Fair Values
Create NarrativeSee what 20 others think this stock is worth. Follow their fair value or set your own to get alerts.
Getinge AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 191.95 |
| 52 Week High | SEK 231.60 |
| 52 Week Low | SEK 175.90 |
| Beta | 0.86 |
| 1 Month Change | 1.59% |
| 3 Month Change | -12.59% |
| 1 Year Change | 1.21% |
| 3 Year Change | -25.72% |
| 5 Year Change | -28.22% |
| Change since IPO | 448.43% |
Recent News & Updates
Recent updates
Getinge AB (publ) Just Missed EPS By 11%: Here's What Analysts Think Will Happen Next
Mar 29
Getinge AB (publ) Just Missed Earnings - But Analysts Have Updated Their Models
Jan 30Return Trends At Getinge (STO:GETI B) Aren't Appealing
Jan 16Some Shareholders Feeling Restless Over Getinge AB (publ)'s (STO:GETI B) P/E Ratio
Jan 02Getinge's (STO:GETI B) Performance Is Even Better Than Its Earnings Suggest
Oct 29These 4 Measures Indicate That Getinge (STO:GETI B) Is Using Debt Reasonably Well
Oct 13Investors Met With Slowing Returns on Capital At Getinge (STO:GETI B)
Sep 27Are Investors Undervaluing Getinge AB (publ) (STO:GETI B) By 50%?
Aug 21Market Participants Recognise Getinge AB (publ)'s (STO:GETI B) Earnings
Jul 09Getinge (STO:GETI B) Shareholders Will Want The ROCE Trajectory To Continue
May 24We Think Getinge (STO:GETI B) Can Stay On Top Of Its Debt
May 08It Looks Like Getinge AB (publ)'s (STO:GETI B) CEO May Expect Their Salary To Be Put Under The Microscope
Apr 16
Paragonix Acquisition And Defense Clearances Boost Growth In Acute Care Therapies
Strategic acquisitions and cybersecurity clearances are expected to open new revenue streams and enhance earnings.Shareholder Returns
| GETI B | SE Medical Equipment | SE Market | |
|---|---|---|---|
| 7D | 0.4% | 2.2% | 4.4% |
| 1Y | 1.2% | -3.5% | 23.1% |
Return vs Industry: GETI B exceeded the Swedish Medical Equipment industry which returned -3.4% over the past year.
Return vs Market: GETI B underperformed the Swedish Market which returned 23.1% over the past year.
Price Volatility
| GETI B volatility | |
|---|---|
| GETI B Average Weekly Movement | 3.5% |
| Medical Equipment Industry Average Movement | 7.3% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in SE Market | 12.9% |
| 10% least volatile stocks in SE Market | 3.7% |
Stable Share Price: GETI B has not had significant price volatility in the past 3 months compared to the Swedish market.
Volatility Over Time: GETI B's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1904 | 11,670 | Mattias Perjos | www.getinge.com |
Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments in Sweden and internationally. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers extracorporeal membrane oxygenation, mechanical ventilation, advanced patient monitoring, ICU infrastructure equipment, and drainage solutions.
Getinge AB (publ) Fundamentals Summary
| GETI B fundamental statistics | |
|---|---|
| Market cap | SEK 52.28b |
| Earnings (TTM) | SEK 2.26b |
| Revenue (TTM) | SEK 34.97b |
Is GETI B overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| GETI B income statement (TTM) | |
|---|---|
| Revenue | SEK 34.97b |
| Cost of Revenue | SEK 18.32b |
| Gross Profit | SEK 16.65b |
| Other Expenses | SEK 14.40b |
| Earnings | SEK 2.26b |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
Apr 21, 2026
| Earnings per share (EPS) | 8.29 |
| Gross Margin | 47.63% |
| Net Profit Margin | 6.46% |
| Debt/Equity Ratio | 31.9% |
How did GETI B perform over the long term?
See historical performance and comparisonDividends
Does GETI B pay a reliable dividends?
See GETI B dividend history and benchmarks| Getinge dividend dates | |
|---|---|
| Ex Dividend Date | Apr 22 2026 |
| Dividend Pay Date | Apr 28 2026 |
| Days until Ex dividend | 9 days |
| Days until Dividend pay date | 15 days |
Does GETI B pay a reliable dividends?
See GETI B dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/04/12 08:01 |
| End of Day Share Price | 2026/04/10 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Getinge AB (publ) is covered by 24 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | ABG Sundal Collier |
| Scott Bardo | Berenberg |
| Delphine Le Louet | Bernstein |